drugset / Trial / NCT00233363

Exploratory Study for Dry Mouth in Patients With Sjögren's Syndrome

NCT00233363

Phase 2 Completed 104 enrolled Otsuka Pharmaceutical Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to exploratively investigate the clinical efficacy of rebamipide on dry mouth in patients with Sjögren's syndrome in comparison with placebo.

Timeline

Start
2005-04-15
Primary completion
2006-01-19
Completion
2006-01-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Rebamipide Small molecule

Indications